510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K820391Substantially Equivalent

Abuscreen Radioimmunoassay for Cannabi

Hoffmann-La Roche, Inc., Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K820391 is the FDA 510(k) clearance record for ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI, a class II device, cleared for Hoffmann-La Roche, Inc. on under FDA product code LAT (Radioimmunoassay, Cannabinoid(S)). FDA records list 49 510(k) clearances for Hoffmann-La Roche, Inc., from to . As of , FDA records show no recalls naming K820391.

Clearance record

Decision date
Received
(26 days to decision)
Product code
LAT Radioimmunoassay, Cannabinoid(S)
Regulation
21 CFR 862.3870
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Hoffmann-La Roche, Inc. 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code LAT

Trailing 12 months

FDA records hold no clearances under product code LAT in the trailing twelve months.

FDA records show no clearances under product code LAT in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LAT, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260